Pediatrix Medical Group, Inc. (MD)

NYSE: MD · Real-Time Price · USD
21.84
+0.08 (0.37%)
At close: Jun 3, 2026, 4:00 PM EDT
21.84
0.00 (0.00%)
After-hours: Jun 3, 2026, 4:10 PM EDT
Market Cap1.75B +36.8%
Revenue (ttm)1.93B -2.3%
Net Income174.22M
EPS2.06
Shares Out 80.19M
PE Ratio10.50
Forward PE9.56
Dividendn/a
Ex-Dividend Daten/a
Volume470,112
Open21.60
Previous Close21.76
Day's Range21.16 - 21.89
52-Week Range11.84 - 24.99
Beta0.71
AnalystsBuy
Price Target23.17 (+5.9%)
Earnings DateMay 5, 2026

About MD

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fe... [Read more]

Sector Healthcare
IPO Date Sep 19, 1995
Employees 4,280
Stock Exchange NYSE
Ticker Symbol MD
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 7 analysts, the average rating for MD stock is "Buy." The 12-month stock price target is $23.17, which is an increase of 5.90% from the latest price.

Price Target
$23.17
(5.90% upside)
Analyst Consensus: Buy
Stock Forecasts

News

HSS Chief of Sports Medicine, Riley J. Williams III, MD, Named FIFA Venue Medical Officer for the 2026 World Cup

NEW YORK--(BUSINESS WIRE)--FIFA World Cup 26™ has named Hospital for Special Surgery (HSS), ranked No. 1 in orthopedics nationally by U.S. News & World Report (2024–2025), Sports Medicine Surgeon, Ril...

Other symbols: III
7 hours ago - Business Wire

Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commerci...

Other symbols: VTGN
15 days ago - Business Wire

Passkey Therapeutics Appoints Mandeep Kaur, MD, MS, as Chief Medical Officer to Advance Clinical Validation of Its Computational Genetics-Based Novel Drug Combination Platform

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Passkey Therapeutics, the architect of the Locksmith® platform for systematically identifying new therapeutic opportunities from synergistic drug combinations, today...

Other symbols: MS
15 days ago - Business Wire

Pediatrix Medical price target raised to $25 from $22 at UBS

UBS raised the firm’s price target on Pediatrix Medical (MD) to $25 from $22 and keeps a Neutral rating on the shares.

22 days ago - TheFly

Pediatrix Medical price target raised to $24 from $21 at Mizuho

Mizuho raised the firm’s price target on Pediatrix Medical (MD) to $24 from $21 and keeps a Neutral rating on the shares.

26 days ago - TheFly

Pediatrix Medical Group Earnings Call Transcript: Q1 2026

Q1 delivered strong adjusted EBITDA of $58M, driven by 4% pricing growth and favorable payer mix, offsetting modest volume declines. Full-year adjusted EBITDA guidance of $280M–$300M is reaffirmed, with pricing expected to remain flat as RCM cash collection impact tapers.

4 weeks ago - Transcripts

Pediatrix Medical Group Quarterly report: Q1 2026

Pediatrix Medical Group has published its Q1 2026 quarterly earnings report on May 5, 2026.

4 weeks ago - Filings

Pediatrix Medical Group Earnings release: Q1 2026

Pediatrix Medical Group released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.

4 weeks ago - Filings

Pediatrix Medical reaffirms FY26 adjusted EBITDA view $280M-$300M

06:10 EDT Pediatrix Medical (MD) reaffirms FY26 adjusted EBITDA view $280M-$300M

4 weeks ago - TheFly

Pediatrix Medical Group Reports First Quarter Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports First Quarter Results.

4 weeks ago - Business Wire

Ambience Healthcare Appoints Michael Han, MD, MBA as Chief Medical Officer

SAN FRANCISCO--(BUSINESS WIRE)--Ambience Healthcare, the leading AI platform for clinical documentation and revenue integrity, today announced the appointment of Michael Han, MD, MBA as Chief Medical ...

5 weeks ago - Business Wire

Pediatrix Medical price target raised to $27 from $24 at Jefferies

Jefferies analyst Jack Slevin raised the firm’s price target on Pediatrix Medical (MD) to $27 from $24 and keeps a Buy rating on the shares. The relative underperformance of healthcare…

6 weeks ago - TheFly

Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026.

6 weeks ago - Business Wire

Pediatrix Medical Group Proxy statement: Proxy filing

Pediatrix Medical Group filed a proxy statement on April 17, 2026, providing details for shareholder voting and corporate governance matters.

6 weeks ago - Filings

Pediatrix Medical price target raised to $23 from $21 at Truist

Truist raised the firm’s price target on Pediatrix Medical (MD) to $23 from $21 and keeps a Hold rating on the shares as part of a broader research note previewing…

7 weeks ago - TheFly

Pediatrix Medical Group Proxy statement: Proxy filing

Pediatrix Medical Group filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Pediatrix Medical Group Proxy statement: Proxy filing

Pediatrix Medical Group filed a proxy statement on March 27, 2026, providing details for shareholder voting and corporate governance matters.

2 months ago - Filings

Pediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal Medicine

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal Medicine.

2 months ago - Business Wire

Pediatrix Welcomes Two Nationally Renowned Physician Leaders

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Welcomes Two Nationally Renowned Physician Leaders.

2 months ago - Business Wire

Pediatrix Medical price target lowered to $22 from $23 at UBS

UBS analyst AJ Rice lowered the firm’s price target on Pediatrix Medical (MD) to $22 from $23 and keeps a Neutral rating on the shares. The ACA headwind remains a…

3 months ago - TheFly

Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Announces 47th Annual NEO: The Conference for Neonatology.

3 months ago - Business Wire

Pediatrix Medical price target lowered to $19 from $21 at Deutsche Bank

Deutsche Bank lowered the firm’s price target on Pediatrix Medical (MD) to $19 from $21 and keeps a Hold rating on the shares. The firm says the company’s volumes were…

3 months ago - TheFly

Pediatrix Medical price target lowered to $21 from $24 at Truist

Truist lowered the firm’s price target on Pediatrix Medical (MD) to $21 from $24 and keeps a Hold rating on the shares. The firm maintained its Hold view following Q4…

3 months ago - TheFly

Pediatrix Medical Group Earnings Call Transcript: Q4 2025

Q4 2025 capped a strong year with adjusted EBITDA of $66M and full-year $276M, driven by favorable payer mix, acuity, and disciplined cost control. 2026 guidance projects flat revenue at $1.9B and 5% EBITDA growth, with steady operational metrics and no M&A included.

3 months ago - Transcripts

Pediatrix Medical Group Earnings release: Q4 2025

Pediatrix Medical Group released its Q4 2025 earnings on February 19, 2026, summarizing the period's financial results.

3 months ago - Filings